Systemic amyloidosis in England: an epidemiological study (Q34975379)

5 August 2017

Systemic amyloidosis in England: an epidemiological study (English)

1 reference

5 August 2017

1 reference

1 reference

Jason Dungu

7

0 references

Helen J Lachmann

object named as

Helen J Lachmann

4

0 references

author name string

Jennifer H Pinney

1

1 reference

5 August 2017

Colette J Smith

2

1 reference

5 August 2017

Jessi B Taube

3

1 reference

5 August 2017

Christopher P Venner

5

1 reference

5 August 2017

Simon D J Gibbs

6

1 reference

5 August 2017

Sanjay M Banypersad

8

1 reference

5 August 2017

Ashutosh D Wechalekar

9

1 reference

5 August 2017

Carol J Whelan

10

1 reference

5 August 2017

Philip N Hawkins

11

1 reference

5 August 2017

Julian D Gillmore

12

1 reference

5 August 2017

language of work or name

English

0 references

publication date

11 March 2013

1 reference

British Journal of Haematology

5 August 2017

1 reference

5 August 2017

161

1 reference

5 August 2017

525-532

1 reference

5 August 2017

4

1 reference

Can mortality data be used to estimate amyotrophic lateral sclerosis incidence?

5 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

Diagnosis, pathogenesis, treatment, and prognosis of hereditary fibrinogen A alpha-chain amyloidosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

Natural history and outcome in systemic AA amyloidosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

Pathogenesis, diagnosis and treatment of systemic amyloidosis

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

The epidemiology of Wegener's granulomatosis. Estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

Mortality rate of amyloidosis in Japan: secular trends and geographical variations

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4296340

The epidemiology of AL and AA amyloidosis.

8 July 2018

1 reference

Burden of mortality associated with autoimmune diseases among females in the United Kingdom.

21 January 2018

1 reference

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis

21 January 2018

1 reference

A phase 1/2 study of lenalidomide with low-dose oral cyclophosphamide and low-dose dexamethasone (RdC) in AL amyloidosis

21 January 2018

1 reference

Organ Transplantation in Hereditary Apolipoprotein AI Amyloidosis

21 January 2018

1 reference

Cyclophosphamide, bortezomib, and dexamethasone therapy in AL amyloidosis is associated with high clonal response rates and prolonged progression-free survival

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.12286

1 reference

5 August 2017

1 reference

5 August 2017

1 reference